Kenneth Gordon to T-Lymphocytes
This is a "connection" page, showing publications Kenneth Gordon has written about T-Lymphocytes.
Connection Strength
0.531
-
From laboratory to clinic: rationale for biologic therapy. Dermatol Clin. 2004 Oct; 22(4):371-7, vii-viii.
Score: 0.159
-
The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S44-50.
Score: 0.147
-
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity. J Dermatolog Treat. 2007; 18(1):13-8.
Score: 0.047
-
Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA. 2003 Dec 17; 290(23):3073-80.
Score: 0.038
-
Evolution of biologic therapies for the treatment of psoriasis. Skinmed. 2003 Sep-Oct; 2(5):286-94.
Score: 0.037
-
Biologic therapy for psoriasis: the new therapeutic frontier. Arch Dermatol. 2002 May; 138(5):657-63.
Score: 0.034
-
Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J Immunol. 1998 May 01; 160(9):4271-9.
Score: 0.026
-
IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol. 1997 Jan 15; 158(2):614-21.
Score: 0.023
-
Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. J Dermatol Sci. 2007 Nov; 48(2):87-101.
Score: 0.012
-
Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood. 2002 May 15; 99(10):3692-701.
Score: 0.008